Method of treating fibrosis in skeletal muscle tissue

Details Method of treating fibrosis in skeletal muscle tissue Method of treating fibrosis in skeletal muscle tissue

1995-10-16

1997-02-18

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514502, 514492, 514493, 514494, 514495, 514498, 514499, 514501, 514505, A61K 3816, A61K 31295

Patent

active

056041993

ABSTRACT:
A method of treating skeletal muscle fibrosis in mammals. The novel method is effective for reducing the extent of skeletal muscle fibrosis in an individual who suffers from a disorder which targets skeletal muscle tissue, such as Duchenne's and Becker's muscular dystrophy and denervation atrophy induced by either trauma or neuromuscular disease. The treatment includes administering to the individual an effective amount of a metalloporphyrin compound, especially hemin, heme arginate, cobalt protoporphyrin IX chloride and cobalt protoporphyrin IX arginate.

REFERENCES:
Sadeh, Menachem et al., Journal of the Neurological Sciences (1985) 67:229-238.
Funanage, V., et al., Abstract: "Hemin Enhances Regeneration of Bipuvacaine-Damaged Rat Skeletal Muscle" American Pediatric Society Meeting, May 7-10, 1990.

Affiliated with

Also associated with

Rating

Method of treating fibrosis in skeletal muscle tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating fibrosis in skeletal muscle tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating fibrosis in skeletal muscle tissue will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1602541